Venrock stocks up on $450M Fund 8 as it prepares a new string of biotech deals
The venture partners at Venrock have an appetite for high-risk biotechs looking to break new ground. Now they have a new $450 million fund to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
